Evidence map›Paper›PMID 41862558›Full record

ArticleScientific reports2026

Molecular study of the small intestine dysbiosis derived from iron deficiency anaemia.

Ana Soriano-Lerma, J Simón Soriano-Suárez, Manuel Garcia-Rodriguez, Maria Jm Alferez, Miguel Soriano, Jose A Garcia Salcedo, Inmaculada Lopez-Aliaga

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana Soriano-LermaCentre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain. anasorler@ugr.ess.
J Simón Soriano-SuárezCentre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
Manuel Garcia-RodriguezCentre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
Maria Jm AlferezDepartment of Physiology (Faculty of Pharmacy), Institute of Nutrition and Food Technology José Mataix, University of Granada, 18071, Granada, Spain.
Miguel SorianoCenter for Intensive Mediterranean Agrosystems and Agri-Food Biotechnology (CIAIMBITAL), University of Almeria, 04001, Almería, Spain. msoriano@ual.es.
Jose A Garcia Salcedo *Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
Inmaculada Lopez-Aliaga *Centre for Genomics and Oncological Research, GENYO, Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.

Funding

Instituto de Salud Carlos III PI21/00497Ministerio de Ciencia e Innovación PID2020-120481RB-100/AEI/10.13039/50110001103Universidad de Almería [P_FORT_CENTROS_2023/09][AS1] , [P_FORT_GRUPOS_2023/102]Universidad de Granada Contratos PUENTE
6 · The paper itself

Abstract

Iron deficiency anaemia (IDA) is closely associated with the gut microbiome, as microbial composition influences iron bioavailability. Small intestinal bacterial overgrowth (SIBO), a form of dysbiosis, may interfere with anaemia treatment, yet it has not been investigated as a direct consequence of iron deficiency. This study aimed to characterize the small intestinal dysbiosis linked to IDA and to identify microbial patterns indicative of SIBO. An animal model of IDA was employed to analyse the microbiome of the small intestine, focusing on community structure and functional properties. Anaemia was confirmed using haematological and biochemical markers. Microbiome profiling was conducted through 16S rRNA gene sequencing. In addition, bacterial load was quantified by 16S rRNA qPCR. qPCR confirmed a significantly elevated bacterial load across all three regions of the small intestine during anaemia, reaching levels compatible with SIBO. A progressive increase was observed in alpha diversity from the jejunum to the ileum during IDA. Taxonomic analysis revealed enrichment of fermentative and colonic-associated species, including Clostridium, Escherichia-Shigella and Lactobacillus. Lastly, functional predictions indicated increased activity in pathways related to carbohydrate fermentation and gas production—metabolic signatures typically linked to SIBO. Iron deficiency was found to induce marked taxonomic and functional alterations in the small intestinal microbiome, especially in distal regions, accompanied by an increased bacterial load. These findings support the concept that iron deficiency promotes microbial shifts characteristic of SIBO, suggesting that iron deficiency may act as a predisposing factor in its pathogenesis.

Indexed as

Anemia, Iron-DeficiencyDysbiosisGastrointestinal MicrobiomeIntestine, SmallAnimalsBacteriaDisease Models, AnimalIronRNA, Ribosomal, 16SIronRNA, Ribosomal, 16SIron deficiencyIron deficiency anaemiaMicrobial functionalitySIBOSmall intestine microbiome

Identifiers

PMID41862558
PMCPMC13144700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.